Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis

Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis

IntroductionPatients with axial spondyloarthritis (axSpA) have a high disease burden mainly due to the rheumatic disease itself, and also exhibit accelerated atherosclerosis, that leads to a higher incidence of cardiovascular (CV) disease. Accordingly, the identification of biomarkers of CV risk and...

Full description

Bibliographic Details
Main Authors:	Sara Remuzgo-Martínez, Javier Rueda-Gotor, Verónica Pulito-Cueto, Raquel López-Mejías, Alfonso Corrales, Leticia Lera-Gómez, Raquel Pérez-Fernández, Virginia Portilla, Íñigo González-Mazón, Ricardo Blanco, Rosa Expósito, Cristina Mata, Javier Llorca, Vanesa Hernández-Hernández, Carlos Rodríguez-Lozano, Nuria Barbarroja, Rafaela Ortega-Castro, Esther Vicente, Cristina Fernández-Carballido, María Paz Martínez-Vidal, David Castro-Corredor, Joaquín Anino-Fernández, Diana Peiteado, Chamaida Plasencia-Rodríguez, Eva Galíndez-Agirregoikoa, María Luz García-Vivar, Nuria Vegas-Revenga, Irati Urionaguena, Oreste Gualillo, Juan Carlos Quevedo-Abeledo, Santos Castañeda, Iván Ferraz-Amaro, Miguel Á. González-Gay, Fernanda Genre
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Series:	Frontiers in Immunology
Subjects:	irisin axial spondyloarthritis biomarker subclinical atherosclerosis cardiovascular risk disease severity
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.894171/full

Similar Items

Vaspin in atherosclerotic disease and cardiovascular risk in axial spondyloarthritis: a genetic and serological study
by: Javier Rueda-Gotor, et al.
Published: (2021-04-01)

Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis
by: Fernanda Genre, et al.
Published: (2020-06-01)

Potential relation of cardiovascular risk factors to disease activity in patients with axial spondyloarthritis
by: Iván Ferraz-Amaro, et al.
Published: (2021-07-01)

Key Molecules of Triglycerides Pathway Metabolism Are Disturbed in Patients With Systemic Lupus Erythematosus
by: Juan Carlos Quevedo-Abeledo, et al.
Published: (2022-05-01)

SCORE2 SCORE in patients with systemic lupus erythematosus
by: Juan Carlos Quevedo-Abeledo, et al.
Published: (2022-04-01)

Full characterization of the three pathways of the complement system in patients with systemic lupus erythematosus
by: María García-González, et al.
Published: (2023-04-01)

Significant sE-Selectin levels reduction after 6 months of anti-TNF-α therapy in non-diabetic patients with moderate-to-severe psoriasis
by: Fernanda Genre, et al.
Published: (2017-11-01)

Management of Cardiovascular Disease Risk in Rheumatoid Arthritis
by: Patrick H. Dessein, et al.
Published: (2022-06-01)

Emigración y fuga de talento en Castilla y León
by: Miguel González Leonardo, et al.
Published: (2019-03-01)

Emigración y fuga de talento en Castilla y León
by: Miguel González Leonardo, et al.
Published: (2019-03-01)

Out-migration and brain drain in Castile and León
by: Miguel González Leonardo, et al.
Published: (2019-03-01)

Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk
by: Iván Ferraz-Amaro, et al.
Published: (2021-06-01)

Endothelial Progenitor Cells: Relevant Players in the Vasculopathy and Lung Fibrosis Associated with the Presence of Interstitial Lung Disease in Systemic Sclerosis Patients
by: Verónica Pulito-Cueto, et al.
Published: (2021-07-01)

Angiogenic T Cells: Potential Biomarkers for the Early Diagnosis of Interstitial Lung Disease in Autoimmune Diseases?
by: Verónica Pulito-Cueto, et al.
Published: (2022-04-01)

Correction: rs17228212 Gene Polymorphism Is Associated with Reduced Risk to Cerebrovascular Accidents and Subclinical Atherosclerosis in Anti-CCP Negative Spanish Rheumatoid Arthritis Patients.
by: Mercedes García-Bermúdez, et al.
Published: (2013-01-01)

Leveraging Genetic Findings for Precision Medicine in Vasculitis
by: Marialbert Acosta-Herrera, et al.
Published: (2019-08-01)

Endothelial Progenitor Cells as a Potential Biomarker in Interstitial Lung Disease Associated with Rheumatoid Arthritis
by: Verónica Pulito-Cueto, et al.
Published: (2020-12-01)

Detection of high cardiovascular risk patients with ankylosing spondylitis based on the assessment of abdominal aortic calcium as compared to carotid ultrasound
by: Javier Rueda-Gotor, et al.
Published: (2018-08-01)

Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study
by: Iván Ferraz-Amaro, et al.
Published: (2021-10-01)

Interregional migration of human capital in Spain
by: Miguel González-Leonardo, et al.
Published: (2022-12-01)

La reactivación de las migraciones internas entre los jóvenes españoles: selectividad migratoria y acumulación del capital humano cualificado
by: Miguel González Leonardo, et al.
Published: (2020-07-01)

Author Correction: BAFF, APRIL and BAFFR on the pathogenesis of Immunoglobulin-A vasculitis
by: Diana Prieto-Peña, et al.
Published: (2021-08-01)

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
by: María García-González, et al.
Published: (2023-08-01)

Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.
by: Mercedes García-Bermúdez, et al.
Published: (2012-01-01)

Analysis of the interferon gamma (rs2430561, +874T/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis.
by: Mercedes García-Bermúdez, et al.
Published: (2012-01-01)

Obesity, Fat Mass and Immune System: Role for Leptin
by: Vera Francisco, et al.
Published: (2018-06-01)

Giant cell arteritis: is the clinical spectrum of the disease changing?
by: Miguel Á. González-Gay, et al.
Published: (2019-07-01)

Interleukin 1 receptor antagonist relation to cardiovascular disease risk in patients with rheumatoid arthritis
by: Cristina Almeida-Santiago, et al.
Published: (2022-08-01)

Levels of the Novel Endogenous Antagonist of Ghrelin Receptor, Liver-Enriched Antimicrobial Peptide-2, in Patients with Rheumatoid Arthritis
by: Vera Francisco, et al.
Published: (2020-04-01)

Transforming growth factor beta 1 is associated with subclinical carotid atherosclerosis in patients with systemic lupus erythematosus
by: Fuensanta Gómez-Bernal, et al.
Published: (2023-04-01)

Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review
by: Belén Atienza-Mateo, et al.
Published: (2020-09-01)

Disease Activity Is More Associated with IL-1 Than with IL-6 in Patients with Rheumatoid Arthritis
by: Cristina Almeida-Santiago, et al.
Published: (2022-12-01)

Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases
by: Verónica Pulito-Cueto, et al.
Published: (2023-01-01)

E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases
by: Verónica Pulito-Cueto, et al.
Published: (2023-08-01)

Correction: Ferraz-Amaro et al. SCORE2 Assessment in The Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. <i>Diagnostics</i> 2021, <i>11</i>, 2363
by: Iván Ferraz-Amaro, et al.
Published: (2022-02-01)

SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis
by: Iván Ferraz-Amaro, et al.
Published: (2021-12-01)

The angiopoietin-like protein 4, apolipoprotein C3, and lipoprotein lipase axis is disrupted in patients with rheumatoid arthritis
by: Laura de Armas-Rillo, et al.
Published: (2022-04-01)

Vascular Endothelial Growth Factor and Its Soluble Receptor in Systemic Lupus Erythematosus Patients
by: Fuensanta Gómez-Bernal, et al.
Published: (2022-12-01)

Serum Levels of Transforming Growth Factor Beta 1 in Systemic Lupus Erythematosus Patients
by: Fuensanta Gómez-Bernal, et al.
Published: (2022-12-01)

Cranial and extracranial giant cell arteritis do not have different HLA-DRB1 and HLA-B association in Caucasian individuals
by: Diana Prieto-Peña, et al.
Published: (2021-10-01)